BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20596921)

  • 1. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma.
    Li S; Du H; Wang Z; Zhou L; Zhao X; Zeng Y
    Sci China Life Sci; 2010 Apr; 53(4):524-30. PubMed ID: 20596921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
    Trimeche M; KsiĆ¢a F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
    Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
    Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series.
    Kattoor J; Koriyama C; Akiba S; Itoh T; Ding S; Eizuru Y; Abraham EK; Chandralekha B; Amma NS; Nair MK
    J Med Virol; 2002 Nov; 68(3):384-9. PubMed ID: 12226826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
    Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
    Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) and gastric carcinoma in Malaysian patients.
    Karim N; Pallesen G
    Malays J Pathol; 2003 Jun; 25(1):45-7. PubMed ID: 16196377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis.
    Tokunaga M; Land CE
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):449-50. PubMed ID: 9610796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between clinical and pathological lymph node evaluation in Epstein-Barr virus-associated gastric cancers.
    Ojima H; Fukuda T; Nakajima T; Takenoshita S; Nagamachi Y
    Anticancer Res; 1996; 16(5B):3081-4. PubMed ID: 8920771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
    van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
    J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction.
    Nishikawa J; Yanai H; Hirano A; Okamoto T; Nakamura H; Matsusaki K; Kawano T; Miura O; Okita K
    Scand J Gastroenterol; 2002 Jul; 37(7):825-9. PubMed ID: 12190097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
    Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
    J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan.
    Koriyama C; Akiba S; Corvalan A; Carrascal E; Itoh T; Herrera-Goepfert R; Eizuru Y; Tokunaga M
    Oncol Rep; 2004 Sep; 12(3):543-7. PubMed ID: 15289835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
    Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
    Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China.
    Chen JN; Ding YG; Feng ZY; Li HG; He D; Du H; Wu B; Shao CK
    J Med Virol; 2010 Apr; 82(4):658-67. PubMed ID: 20166192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus-associated gastric carcinoma in Southern and Northern China.
    Hao Z; Koriyama C; Akiba S; Li J; Luo X; Itoh T; Eizuru Y; Zou J
    Oncol Rep; 2002; 9(6):1293-8. PubMed ID: 12375037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated gastric carcinoma in Lima, Peru.
    Yoshiwara E; Koriyama C; Akiba S; Itoh T; Minakami Y; Chirinos JL; Watanabe J; Takano J; Miyagui J; Hidalgo H; Chacon P; Linares V; Eizuru Y
    J Exp Clin Cancer Res; 2005 Mar; 24(1):49-54. PubMed ID: 15943031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
    Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
    Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathology of Epstein-Barr virus-related gastric carcinoma].
    Itoh T; Tokunaga M
    Nihon Rinsho; 1997 Feb; 55(2):363-7. PubMed ID: 9046824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.